Xia Y - Search Results

1

Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor.

Xu Z, Liu Y, Song B, Ren B, Xu X, Lin R, Zhu X, Chen C, Yang S, Zhu Y, Jiang W, Li W, Xia Y, Hu L, Chen S, Chan CC, Li J, Zhang X, Yang L, Tian X, Ding CZ. Xu Z, et al. Among authors: xia y. Bioorg Med Chem Lett. 2024 Jul 15;107:129769. doi: 10.1016/j.bmcl.2024.129769. Epub 2024 Apr 24. Bioorg Med Chem Lett. 2024. PMID: 38670537

2

Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD).

Dong J, Wang TL, Lu J, Ding CZ, Hu L, Hu G, He H, Zeng X, Li X, Sun D, Zhu Y, Shen L, Gu Q, Chan CC, Xia Y, Li J, Chen S. Dong J, et al. Among authors: xia y. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127601. doi: 10.1016/j.bmcl.2020.127601. Epub 2020 Oct 6. Bioorg Med Chem Lett. 2020. PMID: 33035677

3

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD).

Lu J, Chan CC, Sun D, Hu G, He H, Li J, Dong J, Liu K, Shen L, Hu L, Gu Q, Chen S, Wang T, Gong T, Tang W, Li X, Zhu X, Zeng X, Zhu Y, Xia Y, Huang Y, Zhu Y, Liu Z, Ding CZ. Lu J, et al. Among authors: xia y. Bioorg Med Chem Lett. 2022 Jun 15;66:128734. doi: 10.1016/j.bmcl.2022.128734. Epub 2022 Apr 15. Bioorg Med Chem Lett. 2022. PMID: 35436589

4

A new wave of innovations within the DNA damage response.

Li Q, Qian W, Zhang Y, Hu L, Chen S, Xia Y. Li Q, et al. Among authors: xia y. Signal Transduct Target Ther. 2023 Sep 8;8(1):338. doi: 10.1038/s41392-023-01548-8. Signal Transduct Target Ther. 2023. PMID: 37679326 Free PMC article. Review.

5

Evaluating the quality of home care in community health service centres: A machine learning approach.

Xia Q, Huang Q, Li J, Xu Y, Ge S, Zhang X, Li M, Yu D, Tang X, Xia Y. Xia Q, et al. Among authors: xia y. J Adv Nurs. 2024 May 29. doi: 10.1111/jan.16234. Online ahead of print. J Adv Nurs. 2024. PMID: 38808517

6

RHC genotyping in Chinese Han population.

Shao LN, Zheng ZW, Zhou SH, Song WQ, Xia YX, Liang XH. Shao LN, et al. Among authors: xia yx. BMC Genomics. 2024 May 28;25(1):525. doi: 10.1186/s12864-024-10444-6. BMC Genomics. 2024. PMID: 38807041

7

TriLA: Triple-Level Alignment based Unsupervised Domain Adaptation for Joint Segmentation of Optic Disc and Optic Cup.

Chen Z, Pan Y, Ye Y, Wang Z, Xia Y. Chen Z, et al. Among authors: xia y. IEEE J Biomed Health Inform. 2024 May 28;PP. doi: 10.1109/JBHI.2024.3406447. Online ahead of print. IEEE J Biomed Health Inform. 2024. PMID: 38805331

8

In Situ Characterizations of the Dynamics of Cathode Electrolyte Interfaces at Different Current Densities.

Lv H, Zhou L, Fang Q, Cheng J, Mei J, Xia Y, Wang B. Lv H, et al. Among authors: xia y. Small. 2024 May 28:e2312204. doi: 10.1002/smll.202312204. Online ahead of print. Small. 2024. PMID: 38804909

9

Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1.

Lv X, Wang Z, Wang Z, Yin H, Xia Y, Jiang L, Liu. Lv X, et al. Among authors: xia y. Curr Drug Metab. 2024 May 27. doi: 10.2174/0113892002288312240521092054. Online ahead of print. Curr Drug Metab. 2024. PMID: 38803186

10

Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT images of clear cell renal cell carcinoma.

Lu C, Xia Y, Han J, Chen W, Qiao X, Gao R, Jiang X. Lu C, et al. Among authors: xia y. Sci Rep. 2024 May 27;14(1):12043. doi: 10.1038/s41598-024-60921-x. Sci Rep. 2024. PMID: 38802547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,135 results

Search Page